SCHEMBL8106516

SCHEMBL8106516

N#Cc1ccc(Cc2cnc(Cc3ccc(-c4ccc(C(F)(F)F)cc4)cc3)[nH]2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.54
BRS3 P32247 2/20 0.50
CYP19A1 P11511 1/20 0.46
DGAT1 O75907 1/20 0.44
SOAT1 P35610 1/20 0.44
KCNH2 Q12809 1/20 0.44
HRH3 Q9Y5N1 1/20 0.43
VNN1 O95497 1/20 0.42
MAOB P27338 3/20 0.40
KDM1A O60341 1/20 0.40
DAO P14920 1/20 0.39
SMO Q99835 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP3A5 P20815 1/20 0.38
PTPN5 P54829 1/20 0.37
RXRA P19793 1/20 0.37
RXRG P48443 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
KDM5A P29375 1/20 0.36
KDM4C Q9H3R0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8311538 0.99 KIF11 (0.52) KIF11BRS3CYP19A1DGAT1SOAT1
SCHEMBL8097324 0.89 BRS3 (0.48) KIF11BRS3DGAT1SOAT1KCNH2
Hydrochloric Acid SCHEMBL8306295 0.88 BRS3 (0.47) KIF11BRS3DGAT1SOAT1KCNH2
SCHEMBL8106523 0.85 BRS3 (0.54) BRS3CYP19A1HRH3MAOBKDM1A
SCHEMBL7919393 0.85 BRS3 (0.62) BRS3CYP19A1HRH3
SCHEMBL8105207 0.84 BRS3 (0.53) BRS3CYP19A1HRH3MAOBDAO
Hydrochloric Acid SCHEMBL8521500 0.84 BRS3 (0.61) BRS3CYP19A1HRH3
Trifluoroacetic Acid SCHEMBL8309330 0.83 BRS3 (0.61) BRS3
SCHEMBL7919370 0.83 BRS3 (0.58) BRS3HRH3
Hydrochloric Acid SCHEMBL8310488 0.82 BRS3 (0.57) BRS3HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0986302-A1 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 2000-03-22 EP claimed
EP-0891333-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE Merck & Co., Inc. (US) 1999-01-20 EP claimed
WO-1998054966-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1998-12-10 WO claimed
WO-1997036875-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1997-10-09 WO claimed
EP-0986302-A1 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 2000-03-22 EP disclosed
WO-1998054966-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1998-12-10 WO disclosed